花樣年(01777.HK)擬召開債券持有人會議 審議延期兌付本息議案
花樣年集團(01777.HK)表示,擬在今日(25日)下午召開2020年公開發行公司債券(第二期)2022年第一次債券持有人會議。此次會議將審議《關於同意發行人延期兌付「20花樣02」本金、利息的議案》。本期債券中,回售部分債券的兌付日調整為今年12月25日;未回售部分債券的兌付日不變,仍為2023年11月25日。
另外,付息日及計息期限方面,本期債券中回售部分債券的付息日調整為2021年11月25日、2022年12月25日。未回售部分債券的付息日調整為2021年11月25日、2022年12月25日、2023年11月25日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.